NGM Biopharmaceuticals, Inc

Gordian Biotechnology, located in South San Francisco, is dedicated to discovering new therapies for complex age-related diseases through its proprietary in vivo drug discovery platform. By utilizing innovative methods such as Patient Avatars and Mosaic Screening, the company aims to identify targets and therapies that are most likely to succeed in human trials. With a mission to enhance the quality of life for individuals facing age-related challenges, Gordian's Pythia approach examines the entire transcriptome to assess the effects of various therapies on cellular pathways. Led by CEO Francisco LePort, the company is committed to enabling people to lead longer, healthier lives. Generated from the website

Aimmune Therapeutics is a biopharmaceutical company based in Brisbane, CA, that is dedicated to developing innovative medicines for the treatment, prevention, and management of food, gastrointestinal (GI), and metabolic-related diseases. As a Nestlé Health Science company, Aimmune aims to be a global leader in this field, providing standardized, science-driven treatments for patients and their families who have limited or no other options. With a focus on reducing the burden of serious and potentially life-threatening conditions, Aimmune pushes the boundaries of medicine to enable individuals to live life on their own terms. By uniting the best minds in clinical research and biotechnology, the company is actively working on its pipeline of therapies to address these diseases and improve the lives of patients and caregivers.Generated from the website

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.